{"brief_title": "Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control", "brief_summary": "This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.", "condition": "Diabetes Mellitus, Type 1", "intervention_type": "Drug", "intervention_name": "Placebo", "description": "The placebo injection will be supplied in the same 5-mL multidose glass vials with a rubber stopper.", "arm_group_label": "Placebo", "criteria": "Inclusion Criteria: - HbA1c value between 7.5-9% - Using multiple daily insulin injections", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00042458.xml"}